Impact of Preoperative Treatment of Anemia and Iron Deficiency in Cardiac Surgery on Outcome.

NCT02031289 Phase 4 COMPLETED

We are performing the above prospective randomized trial in 1'000 patients undergoing cardiac surgery. The study will answer the question of whether preoperative treatment of anemia or iron deficiency indeed improves transfusion needs (primary outcome) and important clinical outcomes (secondary outcome) in a large group of cardiac surgical patients. The list of inclusion and exclusion criteria was deliberately chosen short so that this patient group largely reflects today's clinical practice . * Trial with medical product

Details

Lead sponsor	University of Zurich
Phase	Phase 4
Status	COMPLETED
Enrolment	1003
Start date	2013-12
Completion	2018-05

Conditions

• Anemia
• Iron Deficiency

Interventions

• Erythropoietin/Ferric carboxymaltose/Vitamin B12/Folic Acid

Primary outcomes

• Red blood cell (RBC) units transfused — 7 days

Countries

Switzerland